HKSE:09989's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.825 * Ranked among companies with meaningful Dividend Yield % only.
During the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co's average Dividends Per Share Growth Rate was -100.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -17.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 1.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -13.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shenzhen Hepalink Pharmaceutical Group Co was 49.40% per year. The lowest was -46.80% per year. And the median was -20.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Shenzhen Hepalink Pharmaceutical Group Co Dividend Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shenzhen Hepalink Pharmaceutical Group Co Dividend Yield % Chart
Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Dividend Yield %
For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Hepalink Pharmaceutical Group Co's Dividend Yield % Distribution in the Drug Manufacturers Industry
* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Dividend Yield % falls into.
Shenzhen Hepalink Pharmaceutical Group Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Shenzhen Hepalink Pharmaceutical Group Co Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Shenzhen Hepalink Pharmaceutical Group Co Business Description
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business, and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from USA and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09989 has been successfully added to your 